NL-OMON36394尚未招募不适用
Serotonine in cocaine dependence: towards novel diagnostic markers for addicts responsive to behavioural-cognitive therapy - serocaine
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •Male subjects with cocaine dependence as defined in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV; American Psychiatric Association 1994), and will be determined by a structured interview (Composite International Diagnostic Interview: CIDI) aged 18-40 years.
- •Controls: male healthy volunteers aged 18-40 years.
排除标准
- •No cocaine dependence
- •Positive DSM-IV/CIDI for any drug other than cocaine, heroin, alcohol or marijuana
- •Major neurological disorders, claustrophobia, peripheral vascular diseases, current use of respiratory, cardiovascular, anticonvulsant or psychoactive medications (SSRIs), or alexithymia
- •A positive urine test result for amphetamines, barbiturates, benzodiazepine metabolites, cocaine (metabolite), opiates, alcohol, and marijuana
研究者
相似试验
已完成
1 期
Alterations in Serotonergic Functions in Cocaine Addicts - 1Cocaine-Related DisordersNCT00000312National Institute on Drug Abuse (NIDA)
已完成
不适用
Fluoxetine to Reduce Cocaine Use in Cocaine and Opioid AddictsCocaine-Related DisordersOpioid-Related DisordersNCT00142779National Institute on Drug Abuse (NIDA)220
已完成
2 期
Psychopharmacology for Cocaine Dependence - BuspironeCocaine DependenceNCT01267292The University of Texas Health Science Center, Houston50
终止
1 期
A Novel Therapy for cocaine dependence during abstinence: A randomized clinical trialThe inclusion criteria for participation in this study were: 1) having the respective age between 18 and 31ƺ) History of one months of cocaine avoidance,and 3) having at least the educational levelTopiramate,Contingency Management,Craving,Anticonvulsants/adverse effects,Pharmacotherapy,Cocaine DependenceTCTR20170112001non100
终止
2 期
Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2Cocaine-Related DisordersNCT00000310National Institute on Drug Abuse (NIDA)
